Clinical Management of Argatroban in Patients With Heparin Induced Thrombocytopenia Type II

NCT00861692

The purpose of this study is to collect data on the clinical management of Argatroban in patients with suspected or confirmed heparin-induced thrombocytopenia Type II, with or without ongoing thrombosis who require parenteral antithrombotic therapy